ADMA Biologics Inc. - notizie pubblicate 164 - letture 4.413


ADMA Biologics Inc.

ADMA BIOLOGICS INC.

ADMA Biologics Announces Partial Paydown of Revolving Credit Facility

The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer adma biologics inc. published this con ...

14.08.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

ADMA Biologics Announces Partial Paydown of Revolving Credit Facility Form 8 K

Adma biologics announces partial paydown of revolving credit facility cash on hand utilized to repay $30 million of revolving credit facility to ares capital with no prepayment pen ...

14.08.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update

The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer adma biologics inc. published this con ...

09.08.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update Form 8 K

Adma biologics announces second quarter 2024 financial results and provides business update 2q 2024 total revenue of $107.2 million, a 78% increase y-o-y 2q 2024 gaap net income of ...

08.08.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

27.07.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

27.07.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

Initial Statement of Beneficial Ownership - Form 3

Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...

27.07.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

Management Change/Compensation Form 8 K

Item 5.02 departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. promotion of brad tade ...

26.07.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

03.07.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

03.07.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

Certificate of Incorporation/Bylaws Form 8 K

Item 5.03 amendments to articles of incorporation or bylaws; change in fiscal year. on june 27, 2024, the board of directors (the "board") of adma biologics, inc. (the &q ...

28.06.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

15.06.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

Submission of Matters to a Vote of Security Holders Form 8 K

Item 5.07 submission of matters to a vote of security holders adma biologics, inc. (the "company") held its 2024 annual meeting of stockholders (the "annual meeting& ...

04.06.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

Regulation FD Presentation - Form 8-K

The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer adma biologics inc. ...

17.05.2024
ADMA Biologics Inc.

ADMA BIOLOGICS INC.

Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)

United states securities and exchange commission washington, d.c. 20549 form 10-q (mark one) ☒ quarterly report pursuant to section 13 or 15(d) of the securities exchange act of ...

09.05.2024
Condividi